ABU DHABI, United Arab Emirates - Sunday, January 8th 2017 [ME NewsWire]

The American University of Ras Al Khaimah (AURAK) has signed a partnership agreement with the UAE Space Agency, officially putting pen to paper in the federal institution’s head office in Abu Dhabi.

A delegation from the university, consisting of Professor Hassan Hamdan Al Alkim, its president, Professor Mousa Mohsen, dean of the School of Engineering and director of RAK Research and Innovation Center, and Dr. Abdul-Halim Jallad, director of the university’s newly-established ICT Center for Teaching and Creativity in Informatics Communication and Networking (ICONET), attended the signing ceremony.

Prof. Hassan Hamdan Al Alkim welcomed AURAK’s latest agreement, stressing, “We pride ourselves on being a government-owned university and are always eager to contribute to the advancement of this country. This cooperation with the UAE Space Agency represents a significan ... Read more »

Famed Singer and Fashion Icon Partners with World Renowned Beauty Brand

NEW YORK - Wednesday, January 4th 2017 [ME NewsWire]

(BUSINESS WIRE)-- Revlon announced today that Gwen Stefani, singer and international fashion icon, is joining the Revlon family as the newest Global Brand Ambassador. Gwen, a three-time Grammy Award winning singer, songwriter, fashion designer and entrepreneur, will be representing the trend-setting beauty brand in global campaigns beginning this year, featuring Revlon’s empowering Choose Love™ message. Gwen, an inspiration to many by openly choosing love in her own life, is a true style and beauty influencer - as well as a makeup – and now Revlon – lover who has over 15 million devoted social media fans and followers.

“We are thrilled that Gwen Stefani will be representing Revlon as a Global Brand Ambassador,” said Revlon President & CEO Fabian Garcia. “Gwen is a modern-day icon: a G ... Read more »

SlimPort 4K UHD Display Controllers Enable the Highest Resolutions and Fastest Response Times in AR/VR Headsets

SANTA CLARA, Calif. - Friday, January 6th 2017 [ME NewsWire]

(BUSINESS WIRE)-- Analogix Semiconductor, Inc. today announced the availability of its SlimPort® ANX753x/7580 family, the first DisplayPort™ to Quad MIPI-DSI display controllers supporting up to 120 frames per second (FPS) and targeted primarily at virtual reality (VR) and augmented reality (AR) head-mounted displays (HMD). The product family includes:

    ANX7530 – mobile receiver supporting 8 MIPI lanes per eye (total 16 lanes), ideal for popular VR panel resolutions including 1920x2160 per eye;
    ANX7533 – mobile receiver supporting 4 MIPI lanes per eye (total 8 lanes) with display stream compression (DSC), recommended for VR panel resolutions including 1920x1440 per eye.
    ANX7580 – mobile receiver ... Read more »

LAS VEGAS - Friday, January 6th 2017 [ME NewsWire]
(BUSINESS WIRE)-- Business Wire will be making breaking exhibitor news releases available through the CES 2017 Exhibitor News Archive.
The following companies have made electronic press kits available:
3dRudder
Airthings
ARII-PACA / REVA2
Arrayent Inc.
Ashley Chloe Inc.
Ayla Networks
Blue Spark Technologies
Bodytrak
BrainCo Inc.
Case Western Reserve University
Cogilex R&D Inc.
Das Keyboard
First Alert
Foxter
GraalPhone
Happeez
Humanscale
iGulu LLC
Industrial Technology Research Institute (ITRI)
Interlogix
Jasco Products
JETRO (Japan External Trade Organization)
Juiced2Go
Kolibree
Leti
Linkplay
Miliboo
NaturSoftware
Nonda
Ospicon Systems Pte Ltd
Oticon
Phobio
Pioneer Electronics (USA) Inc.
QuietOn Oy (Ltd.)
ReSo ... Read more »

LES ULIS, France - Saturday, January 7th 2017 [ME NewsWire]

(BUSINESS WIRE)-- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of Coagulation Factor VIIa (Recombinant) as a treatment for congenital hemophilia A or B in adolescent and adult congenital hemophilia A or B patients with inhibitors, has been accepted for review by the U.S. Food and Drug Administration (FDA). The BLA contains data from Phase 3 pivotal studies in the global PERSEPT (Program for the Evaluation of Recombinant Factor Seven Efficacy by Prospective Clinical Trials) program, designed to evaluate the safety and efficacy of Coagulation Factor VIIa (Recombinant).

About Eptacog Beta, Activated

Eptacog Beta is an innovative recombinant form of human Factor VIIa. This new chemical entity was developed using LFB SA’s proprietary rPRO™ technology. Eptacog beta is currently under clinical development, and has not received commercial approval ... Read more »